Skip to content
- Day 1: Joshua K. Hartshorne and Laura T. Germain, 2015. When Does Cognitive Functioning Peak? The Asynchronous Rise and Fall of Difference Cognitive Abilities Across the Life Span. Psychological Science.
- Day 2: Anthony I. Barnett and Craig L. Fry, 2015. The Clinical Impact of the Brain Disease Model of Alcohol and Drug Addiction: Exploring the Attitudes of Community-Based AOD Clinicians in Australia. Neuroethics.
- Day 3: Elisabeth Hildt, Klaus Lieb, Christiana Bagusat, and Andreas G. Franke, 2015. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. BioMed Research International.
- Day 4: Susan M. Wolf, et al., 2012. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genetics in Medicine.
- Day 5: Erick H. Cheung and Joseph M. Pierre, 2015. The Medical Ethics of Cognitive Neuroenhancement. AIMS Neuroscience.
- Day 6: Leslie K. Jacobsen, Steven M. Southwick, and Thomas R. Kosten, 2001. Substance Use Disorders in Patients with Post-traumatic Stress Disorder: A Review of the Literature. The American Journal of Psychiatry.
- Day 7: Tim Bayne and Neil Levy, 2005. Amputees By Choice: Body Integrity Identity Disorder and the Ethics of Amputation. Journal of Applied Philosophy.
- Day 8: Dimitris Repantis, Peter Schlattmann, Oona Laisney, and Isabella Heuser, 2010. Modafinil and Methylphenidate for Neuroenhancement in Healthy Individuals: A Systematic Review. Pharmacological Research.
- Day 9: Ding-Lieh Liao, et al., 2014. Cognitive Control in Opioid Dependence and Methadone Maintenance Treatment. PLOS ONE.
- Day 10: Jaarsma P, and Welin S, 2011. Autism as a Natural Human Variation: Reflections on the Claims of the Neurodiversity Movement. Health Care Analysis.
- Day 11: R. Eric Barnes and Helen McCabe, 2012. Should we welcome a cure for autism? A survey of the arguments. Med Health Care Philos.
- Day 12: Brian D. Earp, Anders Sandberg, Guy Kahane, and Julian Savulescu, 2014. When is Dimishment a form of Enhancement? Rethinking the Enhancement Debate in Biomedical Ethics. Frontiers in Systems Neuroscience.
- Day 13: Brian D. Earp, Olga A. Wudarczyk, Anders Sandberg, and Julian Savulescu, 2013. If I Could Just Stop Loving You: Anti-Love Biotechnology and the Ethics of a Chemical Breakup. The American Journal of Bioethics.
- Day 14: Christopher R. Madan, 2014. Augmented Memory: A Survey of the Approaches to Remembering more. Frontiers in Systems Neuroscience.
- Day 15: Josef Syka, 2002. Plastic Changes in the Central Auditory System After Hearing Loss, Restoration of Function, and During Learning. Physiological Reviews.
- Day 16: Su Wooi Teoh, David B. Pisoni, and Richard T. Miyamoto, 2004. Cochlear Implantation in Adults with Prelingual Deafness. Part II. Underlying Constraints that Affect Audiological Outcomes. Laryngoscope.
- Day 17: Teoh SW, Pisoni DB, Miyamoto RT, 2004. Cochlear Implantation in Adults with Prelingual Deafness. Part I. Clinical Results. Laryngoscope.
- Day 18: Leno VC, Charman T, Pickles A, Jones CR, Baird G, Happé F, and Simonoff E, 2015. Callous-Unemotional Trains in Adolescents with Autism Spectrum Disorder. The British Journal of Psychiatry.
- Day 19: David F. Marshall, Alessandra M. Passarotti, Kelly A. Ryan,Masoud Kamali,Erika F.H. Saunders,Bethany Pester,Melvin G. McInnis, and Scott A. Langenecker, 2016. Deficient Inhibitory Control as an Outcome of Childhood Trauma. Psychiatry Research.
- Day 20: Brigit McWade, Damian Milton, and Peter Beresford, 2015. Mad Studies and Neurodiversity: a Dialogue. Disability and Society.
- Day 21: S.B. Sartori, et al., 2002. Magnesium Deficiency Induces Anxiety and HPA Axis Dysregulation: Modulation by Therapeutic Drug Treatment. Neuropharmacology.
- Day 22: Kapp, Steven K.; Gillespie-Lynch, Kristen; Sherman, Lauren E., and Hutman, Ted, 2013. Deficit, difference, or both? Autism and Neurodiversity. Developmental Psychology.
- Day 23: Sarah M. Parsloe, and Austin S. Babrow, 2015. Removal of Asperger’s Syndrome from the DSM V: Community Response to Uncertainty. Health Communication.
- Day 24: Taylor E. Krcek, 2012. Deconstructing Disability and Neurodiversity: Controversial Issues for Autism and Implications for Social Work. Journal of Progressive Human Services.
- Day 25: Kamping S, Andoh J, Bomba IC, Diers M, Diesch E, and Flor H., 2016. Contextual Modulation of Pain in Masochists: Involvement of the Parietal Operculum and Insula. Pain.
- Day 26: Jennifer C. Sarrett, 2016. Biocertification and Neurodiversity: The Role and Implications of Self-Diagnosis in Autistic Communities. Neuroethics.
- Day 27: Kumar B. Rajan, Robert S. Wilson, Jennifer Weuve, Lisa L. Barnes, and Denis A. Evans., 2015. Cognitive Impairment 18 years before Clinical Diagnosis of Alzheimer Disease Dementia. Neurology.
- Day 28: Beate Ochsner, Markus Spöhrer, and Robert Stock, 2015. Human, Non-Human, and Beyond: Cochlear Implants in Socio-Technological Environments. Nanoethics.
- Day 29: Cynthia Forlini, and Wayne Hall, 2015. The is and ought of the Ethics of Neuroenhancement: Mind the Gap. Frontiers in Psychology.
- Day 30: Manfred Hintermair, and John A. Albertini, 2005. Ethics, Deafness, and New Medical Technologies. Journal of Deaf Studies and Deaf Education.
- Day 31: Martha J. Farah, Judy Illes, Robert Cook-Deegan, Howard Gardner, Eric Kandel, Patricia King, Eric Parens, Barbara Sahakian, and Paul Root Wolpe, 2004. Neurocognitive Enhancement: what can we do and what should we do? Science and Society.